Skip to content

MedRhythms

3 viewers · 30d

Total raised

$2.9M

1 filing since 2025 · latest Debt filed

Cumulative raised
LAST ROUND
Debt · $2.9M
ROUNDS
1
INVESTORS
3
FOUNDED
N/A
HQ
Portland, ME
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

MedRhythms, Inc. is a pioneering digital therapeutics company dedicated to transforming healthcare for individuals suffering from neurologic injuries and diseases. By harnessing the intricate link between music and neuroscience, the company focuses on developing innovative therapeutic solutions aimed at addressing mobility challenges and enhancing functional outcomes for affected individuals.

What sets it apart

MedRhythms uniquely integrates music therapy with advanced technology to create personalized rehabilitation solutions that address mobility impairments.

Funding history

1 round
Debt+1Mar 28, 2025
Form D
+$2.9M$2.9M total

Latest SEC filings

via EDGAR · CIK 0001746125
Form D · Mar 28, 2025View on EDGAR

Products

1 tracked

Digital Therapeutic Platform

Rehabilitation Technology

MedRhythms' flagship product is a sophisticated digital therapeutic platform that utilizes patented technology combining music, sensors, and software. It employs the principle of Rhythmic Auditory Stimulation (RAS) to deliver clinically validated treatments that significantly improve walking impairments by retraining motor functions through rhythm-based neural stimulation.

  • Integration of wearable sensors to monitor patient progress
  • Adaptive algorithms for personalized therapy
  • Clinical research-backed efficacy
  • Utilization of personalized music through partnership with Universal Music Group